Generate Biomedicines
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GENB and other ETFs, options, and stocks.About GENB
Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.
GENB Key Statistics
Stock Snapshot
Generate Biomedicines(GENB) stock is priced at $12.26, giving the company a market capitalization of 1.56B.
On 2026-03-18, Generate Biomedicines(GENB) stock moved within a range of $12.21 to $12.79. With shares now at $12.26, the stock is trading +0.4% above its intraday low and -4.2% below the session's peak.
Trading volume for Generate Biomedicines(GENB) stock has reached 39.64K, versus its average volume of 758.21K.
The stock's 52-week range extends from a low of $11.00 to a high of $15.32.
The stock's 52-week range extends from a low of $11.00 to a high of $15.32.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.